Italy Cardiac Surgery Instruments Market, By Product (Forceps, Clamps, Scalpels, Scissors, Needle Holders, Others), By Application (Coronary Artery Bypass Grafting, Heart Valve Surgery, Pediatric Surgery, Heart Transplant, Others), By End User (Hospitals, Ambulatory Surgical Centers), By Region, Competition, Forecast & Opportunities, 2021-2031F

Key Insights	Details
Forecast Period	2027-2031
Market Size (2025)	USD 2.41 Billion
CAGR (2026-2031)	6.87%
Fastest Growing Segment	Forceps
Largest Market	North-West
Market Size (2031)	USD 3.59 Billion

Market Overview

The Italy Cardiac Surgery Instruments Market will grow from USD 2.41 Billion in 2025 to USD 3.59 Billion by 2031 at a 6.87% CAGR. Cardiac surgery instruments encompass a specialized array of tools essential for interventions on the heart and associated vasculature, including sternal retractors, various forceps, scissors, vascular clamps, and needle holders for meticulous tissue manipulation and suturing. The Italy Cardiac Surgery Instruments Market is primarily driven by the country's aging demographic and the high incidence of cardiovascular diseases. Furthermore, the increasing adoption of minimally invasive surgical techniques, which necessitate advanced and specialized instrumentation, propels market expansion. Investments in modernizing healthcare infrastructure and sustained expenditure on advanced medical technologies also contribute significantly to growth. According to the National Association of Hospital Cardiologists (ANMCO), as of May 2026, cardiovascular diseases affect nearly 10 million individuals in Italy, representing the primary cause of hospital admission.

Despite these drivers, a significant impediment to market expansion is the persistent shortage of highly specialized healthcare professionals, such as certified clinical perfusionists and surgical teams, crucial for operating complex advanced cardiac systems. This scarcity can limit the optimal utilization of sophisticated instrumentation and constrain the volume of advanced cardiac procedures performed.

Key Market Drivers

Rising cardiovascular disease prevalence drives instrument demand
The rising prevalence of cardiovascular diseases directly fuels demand within the Italy Cardiac Surgery Instruments Market by increasing the volume of necessary surgical interventions. This escalating disease burden necessitates a continuous supply of specialized instruments for diagnoses and treatments. For instance, according to the Italian Health Examination Survey – CUORE Project, published in May 2026, the mean 10-year fatal and non-fatal cardiovascular disease risk assessment for men aged 35-69 years was 7.5%, indicating a significant underlying risk profile within a substantial segment of the adult population. Such high-risk cohorts translate into a sustained requirement for sternal retractors, vascular clamps, and various other precise tools vital for complex procedures, including coronary artery bypass grafting and valve repairs.

Aging population increases demand for cardiac instruments
The aging population demographics in Italy further intensify this demand, as older individuals are more susceptible to age-related cardiac conditions requiring surgical correction. As of March 2026, Istat's "Demographic Indicators – Year 2025" revealed that the population aged 65 and over in Italy reached 14.821 million individuals, constituting 25.1% of the total population. This demographic shift necessitates a robust healthcare infrastructure equipped with a full spectrum of cardiac surgery instruments to manage the increasing caseload of conditions like valvular heart disease and aortic aneurysms. This consistent demand underpins market stability and growth, with a notable volume of intricate procedures performed nationwide. According to We the Italians, in April 2026, 4,692 organ transplants were performed nationwide in Italy in 2024.

Download Free Sample Report

Key Market Challenges

Workforce Shortages Constrain Instrument Utilization
A significant impediment to the expansion of the Italy Cardiac Surgery Instruments Market is the persistent shortage of highly specialized healthcare professionals, including certified clinical perfusionists and surgical teams. This scarcity directly limits the optimal utilization of advanced and intricate instrumentation, thereby constraining the volume of complex cardiac procedures that can be performed across the country. The sophisticated nature of modern cardiac surgery demands a skilled and adequate workforce to operate and manage the specialized equipment, without which investments in advanced technologies cannot yield their full potential in terms of patient care or market growth.

Staff Shortages Extend Cardiology Waiting Lists
This professional deficit directly contributes to prolonged waiting lists for cardiac interventions. According to an ANMCO Position paper published in October 2025, waiting lists in cardiology represent one of the most significant problems within the Italian Health Service, directly impacted by issues related to the number of medical personnel. The insufficient availability of these critical staff members directly translates to fewer surgical procedures, consequently restraining the demand for new and replacement cardiac surgery instruments in the Italian market.

Key Market Trends

TAVR Expansion Drives Demand for Specialized, Efficient Instruments
The expansion of Transcatheter Heart Valve Procedures (THVP), particularly Transcatheter Aortic Valve Replacement (TAVR), represents a significant trend in the Italian cardiac surgery instruments market. This minimally invasive approach increasingly serves patients across a broader risk spectrum, shifting demand towards specialized catheters, delivery systems, and advanced imaging guidance tools. As TAVR procedures become more standardized and integrated into clinical practice, the emphasis is on efficiency and patient recovery. For example, fast-track protocols for TAVR patients were implemented in 68% of surveyed high-volume cardiac surgery centers in Italy. This development underscores the demand for instruments that facilitate streamlined workflows and rapid patient mobilization.

AI and Robotic Technologies Redefine Cardiac Instrumentation
Another influential trend is the integration of advanced digital and artificial intelligence (AI) technologies into cardiac surgery. This involves the adoption of robotic-assisted surgical systems with enhanced visualization, precision, and data analytics capabilities, fundamentally altering the instrument landscape. Such technologies enable surgeons to perform complex procedures with greater accuracy and less invasiveness, fostering demand for compatible robotic instrumentation, intelligent sensors, and integrated software platforms. According to the Italian Federation of Healthcare Organizations and Hospitals (FIASO), as of November 2025, over 40 operational solutions leveraging artificial intelligence have been collected through its call for practice, demonstrating a growing embrace of digital innovation to improve patient outcomes and operational efficiency within the Italian healthcare sector.

Segmental Insights

Growth Drivers and Regulatory Oversight for Italy's Forceps Market
The forceps segment is experiencing rapid growth in the Italy Cardiac Surgery Instruments Market, primarily driven by the increasing prevalence of cardiovascular diseases requiring surgical intervention. The rising adoption of minimally invasive cardiac surgery techniques further propels this demand, as these advanced procedures necessitate highly precise instrumentation for delicate tissue handling, suturing, and vessel control. Forceps are essential tools in these evolving surgical methods. Regulatory oversight by entities such as the Italian Ministry of Health and the Italian Medicines Agency (AIFA) ensures adherence to strict quality and safety standards for medical devices, fostering trust and continuous innovation in the segment. This dynamic environment underscores the sustained expansion of the forceps market.

Regional Insights

North-West Leads Italy's Cardiac Surgery Instrument Market
The North-West region leads the Italy Cardiac Surgery Instruments Market due to its advanced and well-established healthcare infrastructure. This area benefits from a high concentration of specialized cardiac centers and prominent academic hospitals, particularly in cities like Milan, which are recognized for their expertise and substantial surgical volumes. Strong collaboration between public and private healthcare entities, combined with elevated per capita healthcare expenditure, supports the early adoption of innovative cardiovascular technologies. These factors collectively position the North-West as a key hub for complex cardiac interventions, thus driving demand for advanced surgical instrumentation.

Recent Developments

• In October 2025, Medtronic Cardiac Surgery announced the European launch of its VitalFlow™ Extracorporeal Membrane Oxygenation (ECMO) system. This configurable, integrated ECMO solution was developed to simplify and enhance performance in critical care settings, bridging the gap between bedside care and intra-hospital transport for critically ill patients. The introduction of this advanced system in Europe expanded Medtronic's comprehensive cardiac surgery portfolio and directly provided Italian hospitals with sophisticated instruments for life-saving cardiopulmonary support in cardiac surgical procedures.
• In August 2025, the Italian company Esaote Group showcased new AI-powered solutions for cardiac ultrasound at the European Society of Cardiology (ESC) Congress. This included the launch of the MyLab™C30 cardio, a portable ultrasound system specifically engineered for cardiology, and HeartScan Assistant, an AI-powered feature designed to assist in acquiring transthoracic cardiac ultrasound images. These innovations, by an Italian firm, aimed to enhance diagnostic precision and streamline workflows for cardiologists, offering crucial advancements that directly influence preoperative assessment and planning within the Italy Cardiac Surgery Instruments Market.
• In October 2024, Medtronic launched the Avalus Ultra™ valve in Western Europe during the European Association for Cardio-Thoracic Surgery (EACTS) Congress. This next-generation bovine pericardial valve for aortic valve replacement built upon the existing Avalus™ platform, emphasizing ease of implant and designed for long-term durability. The introduction of such advanced surgical heart valves in the European market, including Italy, expanded the portfolio of cardiac surgery instruments available to healthcare professionals, supporting efforts to improve patient care within the Italy Cardiac Surgery Instruments Market.
• In May 2024, Edwards Lifesciences introduced its SAPIEN 3 Ultra RESILIA valve in Europe, an advancement for patients with heart valve disease. This transcatheter heart valve system received CE Mark approval, allowing its use for individuals suffering from native calcific aortic stenosis or failed bioprosthetic valves across various surgical risk levels. The RESILIA tissue technology, incorporated into the valve, resulted from extensive research and development aimed at enhancing durability and improving patient outcomes in cardiac surgery, directly impacting the availability of advanced instruments in the Italy Cardiac Surgery Instruments Market.

Key Market Players

• Medtronic plc
• Johnson & Johnson
• B. Braun Melsungen AG
• Stryker Corporation
• Boston Scientific Corporation
• Getinge AB
• Terumo Corporation
• Edwards Lifesciences Corporation
• Zimmer Biomet Holdings, Inc.
• Smith & Nephew plc

By Product	By Application	By End User	By Region
Forceps Clamps Scalpels Scissors Needle Holders Others	Coronary Artery Bypass Grafting Heart Valve Surgery Pediatric Surgery Heart Transplant Others	Hospitals Ambulatory Surgical Centers	South North-West Central North-East

Report Scope:

In this report, the Italy Cardiac Surgery Instruments Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Italy Cardiac Surgery Instruments Market, By Product:

• Forceps
• Clamps
• Scalpels
• Scissors
• Needle Holders
• Others

• Italy Cardiac Surgery Instruments Market, By Application:

• Coronary Artery Bypass Grafting
• Heart Valve Surgery
• Pediatric Surgery
• Heart Transplant
• Others

• Italy Cardiac Surgery Instruments Market, By End User:

• Hospitals
• Ambulatory Surgical Centers

• Italy Cardiac Surgery Instruments Market, By Region:

• South
• North-West
• Central
• North-East